SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001144204-18-065906
Filing Date
2018-12-21
Accepted
2018-12-21 12:23:02
Documents
4
Effectiveness Date
2018-12-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv509010-defm14a.htm DEFM14A 2649333
2 GRAPHIC lg_oppenheimer.jpg GRAPHIC 31677
3 GRAPHIC tv509010_pc1.jpg GRAPHIC 196052
4 GRAPHIC tv509010_pc2.jpg GRAPHIC 122873
  Complete submission text file 0001144204-18-065906.txt   3133559
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38114 | Film No.: 181248430
SIC: 2834 Pharmaceutical Preparations